相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Outcome of 1000 Patients With Gastrointestinal Stromal Tumor (GIST) Treated by Surgery in the Pre- and Post-imatinib Eras
Michael J. Cavnar et al.
ANNALS OF SURGERY (2021)
Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Treated With Tyrosine Kinase Inhibitors A 2-institutional Analysis
Mark Fairweather et al.
ANNALS OF SURGERY (2018)
Immortal Time Bias in Observational Studies of Time-to-Event Outcomes: Assessing Effects of Postmastectomy Radiation Therapy Using the National Cancer Database
Parul Agarwal et al.
CANCER CONTROL (2018)
Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate-or High-Risk Primary Gastrointestinal Stromal Tumor The PERSIST-5 Clinical Trial
Chandrajit P. Raut et al.
JAMA ONCOLOGY (2018)
Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome
Michael J. Cavnar et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach
Yukinori Kurokawa et al.
BRITISH JOURNAL OF CANCER (2017)
Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas
Paolo G. Casali et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib - Analysis of prognostic factors (EORTC-STBSG collaborative study)
S. Bauer et al.
EJSO (2014)
Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial
Christopher L. Corless et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Surgical Management of Advanced Gastrointestinal Stromal Tumors: An International Multi-Institutional Analysis of 158 Patients
Danielle A. Bischof et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2014)
Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience
Piotr Rutkowski et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132
Dian Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor A Randomized Trial
Heikki Joensuu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts
Heikki Joensuu et al.
LANCET ONCOLOGY (2012)
Phase II Trial of Neoadjuvant/Adjuvant Imatinib Mesylate (IM) for Advanced Primary and Metastatic/Recurrent Operable Gastrointestinal Stromal Tumor (GIST): Early Results of RTOG 0132/ACRIN 6665
Burton L. Eisenberg et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
Ronald P. DeMatteo et al.
LANCET (2009)
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis
Jason S. Gold et al.
LANCET ONCOLOGY (2009)
Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)
Ronald P. DeMatteo et al.
CANCER (2008)
We should desist using RECIST, at least in GIST
Robert S. Benjamin et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Results of tyrosine-kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor
Ronald P. DeMatteo et al.
ANNALS OF SURGERY (2007)
Surgical resection of gastrointestinal stromal tumors after treatment with imatinib
Robert H. I. Andtbacka et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain
J. Rubio et al.
EUROPEAN JOURNAL OF CANCER (2007)
Gastrointestinal stromal tumors: Pathology and prognosis at different sites
Markku Miettinen et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2006)
Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: A review
M Miettinen et al.
HUMAN PATHOLOGY (2002)
Diagnosis of gastrointestinal stromal tumors: A consensus approach
CDM Fletcher et al.
HUMAN PATHOLOGY (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Two hundred gastrointestinal stromal tumors - Recurrence patterns and prognostic factors for survival
RP DeMatteo et al.
ANNALS OF SURGERY (2000)
分享论文
